PI
PTCT icon

Putnam Investments’s PTC Therapeutics PTCT Stock Holding History

Putnam Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.23M Sell
44,809
-1,409
-3% -$32.2K ﹤0.01% 821
2023
Q3 		$1.04M Sell
46,218
-401
-0.9% -$14.9K ﹤0.01% 830
2023
Q2 		$1.9M Sell
46,619
-1,573
-3% -$77K ﹤0.01% 744
2023
Q1 		$2.33M Sell
48,192
-12,175
-20% -$557K ﹤0.01% 686
2022
Q4 		$2.3M Buy
60,367
+21,673
+56% +$901K ﹤0.01% 693
2022
Q3 		$1.94M Buy
+38,694
New +$1.9M ﹤0.01% 735
2021
Q1 		– Sell
-63,862
Closed -$3.9M – 826
2020
Q4 		$3.9M Sell
63,862
-11,115
-15% -$655K 0.01% 535
2020
Q3 		$3.5M Sell
74,977
-32,089
-30% -$1.58M 0.01% 540
2020
Q2 		$5.43M Buy
107,066
+17,451
+19% +$857K 0.01% 453
2020
Q1 		$4M Buy
89,615
+5,417
+6% +$273K 0.01% 484
2019
Q4 		$4.04M Buy
+84,198
New +$3.58M 0.01% 562
2016
Q4 		– Sell
-218,100
Closed -$3.06M – 1282
2016
Q3 		$3.06M Sell
218,100
-1,900
-0.9% -$15.4K 0.01% 721
2016
Q2 		$1.54M Hold
220,000
– – ﹤0.01% 1001
2016
Q1 		$1.42M Sell
220,000
-1,229,289
-85% -$21.3M ﹤0.01% 1033
2015
Q4 		$47M Buy
1,449,289
+470,623
+48% +$13.9M 0.11% 182
2015
Q3 		$26.1M Sell
978,666
-208,598
-18% -$8.92M 0.06% 263
2015
Q2 		$57.1M Buy
1,187,264
+338,476
+40% +$19.7M 0.11% 188
2015
Q1 		$51.6M Buy
848,788
+629,488
+287% +$38.4M 0.1% 206
2014
Q4 		$11.4M Hold
219,300
– – 0.02% 469
2014
Q3 		$9.65M Hold
219,300
– – 0.02% 498
2014
Q2 		$5.73M Sell
219,300
-800
-0.4% -$17.1K 0.01% 727
2014
Q1 		$5.75M Buy
220,100
+160,100
+267% +$4.3M 0.01% 700
2013
Q4 		$1.02M Hold
60,000
– – ﹤0.01% 1196
2013
Q3 		$1.29M Buy
+60,000
New +$1.04M ﹤0.01% 1165

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Putnam Investments's PTCT Position: Q4 2023 in Review

Putnam Investments reduced its PTC Therapeutics (PTCT) stake by 3% in Q4 2023, selling an estimated $32.2K and leaving 44,809 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #821.

Putnam Investments first reported a position in PTCT in Q3 2013 and has held it in 24 quarters since. The position peaked at $57.1M in Q2 2015. 172 funds tracked by Wall St. Rank hold PTCT as of Q4 2023.

  • Putnam Investments held 44,809 shares of PTC Therapeutics worth $1.23M as of Q4 2023.
  • Putnam Investments sold 1,409 PTC Therapeutics shares in Q4 2023, an estimated $32.2K.
  • PTC Therapeutics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #821 holding.
  • Putnam Investments first reported a position in PTC Therapeutics in Q3 2013 and has held it in 24 quarters since.
  • Putnam Investments's PTC Therapeutics position peaked at $57.1M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.